 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: 6-mercaptopurine | Purinethol® | Xaluprine®
                                 mercaptopurine is an approved drug (FDA (1953), EMA (2012)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Mercaptopurine has immunosuppressive action as well as antineoplastic activity.
                                    
                                   View more information in the IUPHAR Pharmacology Education Project: 6-mercaptopurine | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| Mercaptopurine is used to treat acute leukemia. | 
| Mechanism Of Action and Pharmacodynamic Effects  | 
| Mercaptopurine is a purine analogue which interferes with nucleic acid biosynthesis. ChEMBL also cite amidophosphoribosyltransferase (PPAT, Q06203) as a target of this drug. This enzyme catalyses the first step in de novo purine synthesis. | 
| External links  | 
| For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA) |